BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18436290)

  • 1. Vena caval reconstruction during postchemotherapy retroperitoneal lymph node dissection for metastatic germ cell tumor.
    Ehrlich Y; Kedar D; Zelikovski A; Konichezky M; Baniel J
    Urology; 2009 Feb; 73(2):442.e17-9. PubMed ID: 18436290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
    Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
    Brown JA; Bihrle R; Foster RS
    Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor.
    Miki T; Mizutani Y; Nakamura T; Kawauchi A; Nagahara A; Nonomura N; Okuyama A
    Int J Urol; 2009 Apr; 16(4):379-82. PubMed ID: 19191930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Tal R; Sheinfeld J
    J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of the inferior vena cava without reconstruction for urologic malignancies.
    Duty B; Daneshmand S
    Urology; 2009 Dec; 74(6):1257-62. PubMed ID: 19819533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
    Spiess PE; Tannir NM; Tu SM; Brown GA; Liu P; Kamat AM; Wood CG; Evans JG; Pisters LL
    Cancer; 2007 Dec; 110(12):2700-8. PubMed ID: 17948916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
    Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retroperitoneal lymph node dissection for patients with advanced testicular tumor].
    Takasaki N; Ueda H; Isurugi K
    Hinyokika Kiyo; 1994 Oct; 40(10):957-61. PubMed ID: 7992714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Temporary transsection of the inferior vena cava for complete removal of a retroperitoneal metastatic testicular tumor].
    Kumada K; Okada Y; Okada K; Morikawa S; Yoshida O
    Chirurg; 1988 Oct; 59(10):676-8. PubMed ID: 2848663
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumferential resection of the inferior vena cava for primary and recurrent malignant tumors.
    Caso J; Seigne J; Back M; Spiess PE; Pow-Sang J; Sexton WJ
    J Urol; 2009 Sep; 182(3):887-93. PubMed ID: 19616230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
    Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
    BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results].
    Tavolini IM; Norcen M; Oliva G; Nigro F; Benedetto G; Mazzariol C; Bassi P
    Arch Ital Urol Androl; 2002 Jun; 74(2):69-76. PubMed ID: 12161940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal lymph node dissection in the treatment of patients with non-seminoma testicular tumours.
    Kułakowski A; Dardziński R
    Eur J Surg Oncol; 1991 Dec; 17(6):581-4. PubMed ID: 1660411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors.
    Nguyen CT; Stephenson AJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer.
    Beck SD; Lalka SG
    J Vasc Surg; 1998 Nov; 28(5):808-14. PubMed ID: 9808847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.
    Johnson SC; Smith ZL; Nottingham C; Schwen ZR; Thomas S; Fishman EK; Lee NJ; Pierorazio PM; Eggener SE
    Urology; 2019 Jan; 123():186-190. PubMed ID: 30179635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.